Tsurumi M, Oka M, Hazama S, Yano K, Uchiyama T, Suzuki T
Dept. of Surgery II, Yamaguchi University School of Medicine.
Gan To Kagaku Ryoho. 1992 Aug;19(10 Suppl):1584-6.
We studied complications of the infusion catheter, which were implanted in the hepatic artery under laparotomy, and then connected with an implantable infuser port in patients with hepatocellular carcinoma (n = 32) and metastatic liver tumor (n = 11). Infuse-A-Port catheter was used for 31 cases (A group), and Anthron P-U catheter for 12 cases (B group). In B group, the cannulation method was changed; the catheter was placed in the hepatic artery via the gastroduodenal artery, which was ligated and cut to prevent kinks in the catheter. In the A group, 17 cases (54.8%) showed complications such as dislocation of the catheter tip (7 cases) including penetrating duodenal ulcer (2 cases), arterial occlusion (6 cases), injury of catheter (2 cases) and occlusion of the infuser port (2 cases). One case, however, having a fistula between the hepatic artery and the duodenum, died of sudden massive bleeding. In the B group, 3 cases (25.0%) showed complications such as dislocation of the catheter tip (1 case) and arterial occlusion (2 cases). The catheter in B group lasted longer than that in A group. Thus, our cannulation technique using Anthron P-U catheter may decrease the catheter complications.
我们研究了在剖腹手术中植入肝动脉并与植入式输液港相连的输液导管的并发症,这些患者包括肝细胞癌患者(n = 32)和肝转移瘤患者(n = 11)。31例使用Infuse - A - Port导管(A组),12例使用Anthron P - U导管(B组)。在B组中,插管方法有所改变;导管经胃十二指肠动脉置入肝动脉,胃十二指肠动脉被结扎切断以防止导管扭曲。在A组中,17例(54.8%)出现并发症,如导管尖端移位(7例),包括穿透性十二指肠溃疡(2例)、动脉闭塞(6例)、导管损伤(2例)和输液港阻塞(2例)。然而,有1例肝动脉与十二指肠之间形成瘘管,死于突然大量出血。在B组中,3例(25.0%)出现并发症,如导管尖端移位(1例)和动脉闭塞(2例)。B组导管的使用时间比A组更长。因此,我们使用Anthron P - U导管的插管技术可能会减少导管并发症。